Skip to main content

Published locations for Upadacitinib shows favorable long-term benefit-risk profile in moderate-to-severe atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Upadacitinib shows favorable long-term benefit-risk profile in moderate-to-severe atopic dermatitis

User login

  • Reset your password
  • /content/upadacitinib-shows-favorable-long-term-benefit-risk-profile-moderate-severe-atopic
  • /dermatology/article/252928/atopic-dermatitis/upadacitinib-shows-favorable-long-term-benefit-risk